RxDoctor Payments DataLook up a doctor →

Kevin Suttmoeller, DO

Internal Medicine · Kansas City, MONPI 1144201914

Payments from drug & device makers

$197,922in general payments, 2019–2025

Across 878 payments — averaging $225.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$186K
  • AbbVie$2K
  • AstraZeneca$1K
  • Lilly USA, LLC$1K
  • Regeneron Healthcare Solutions, Inc.$572
  • GSK$538
  • plus $6K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk232$186,356
AbbVie(2 entities)112$1,829
AstraZeneca58$1,199
Lilly USA, LLC67$1,142
Regeneron Healthcare Solutions, Inc.18$572
GSK39$538
Boehringer Ingelheim31$511
Amgen30$478
Johnson & Johnson29$469
Pfizer31$379
Sanofi13$307
Merck19$306
Nevro Corp.7$294
United Therapeutics Corporation10$218
Jazz Pharmaceuticals Inc.8$202
Abbott11$200
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC12$191
Currax Pharmaceuticals LLC12$182
Sumitomo Pharma America, Inc.12$180
Eisai Inc.11$178
Insulet Corporation4$157
Astellas Pharma US Inc8$133
Axsome Therapeutics, Inc.6$127
Grifols USA, LLC5$102
Harmony Biosciences LLC5$101
E.r. Squibb & Sons, L.L.C.5$93
Vivus LLC6$81
Novartis5$79
Idorsia Pharmaceuticals US Inc5$77
Amarin Pharma, Inc.5$75
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$68
Biohaven Pharmaceutical Holding Company Ltd.3$68
Baxter Healthcare4$60
Teva Pharmaceuticals USA, Inc.3$58
Boston Scientific3$58
Mylan Specialty L.p.4$57
Ardelyx, Inc.2$51
Sanofi Pasteur Inc.2$49
Biogen2$48
Radius Health, Inc.2$47
Inogen, Inc.2$47
Shield Therapeutics Inc2$44
Neurocrine Biosciences, Inc.2$43
IBSA Pharma Inc.2$42
Daiichi Sankyo Inc.2$40
Cequr Corporation1$39
Alnylam Pharmaceuticals Inc.2$35
Otsuka America Pharmaceutical, Inc.2$33
Bayer2$30
Nalpropion Pharmaceuticals LLC2$28
Xeris Pharmaceuticals, Inc.2$26
Amneal Pharmaceuticals LLC1$25
Esperion Therapeutics, Inc.2$25
Tactile Systems Technology Inc1$22
Sunovion Pharmaceuticals Inc.1$20
Genentech USA, Inc.1$19
Exact Sciences1$17
Actelion Pharmaceuticals US, Inc.1$15
Organogenesis Inc.1$15
Endo Pharmaceuticals Inc.1$14

How this compares

$197,922 in reported general payments places this provider in the 95th percentile of 2,097 internal medicine providers in Missouri.

See all internal medicine providers in Missouri →

Medicare billing

Part B allowed, 2024
$67,189
Medicare patients
173
Services billed
716

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Kansas City

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →